Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
An Expanded Access Treatment Plan for the Use of BLENREP® (belantamab mafodotin) (GSK2857916) in a Single Patient with Multiple Myeloma
Complete Title: An Expanded Access Treatment Plan for the Use of BLENREP® (belantamab mafodotin) (GSK2857916) in a Single Patient with Multiple Myeloma
Trial Phase: N/A
Investigator: Edmond Marzbani
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
N/A
Edmond Marzbani
RG1123213
An Expanded Access Treatment Plan for the Use of BLENREP® (belantamab mafodotin) (GSK2857916) in a Single Patient with Multiple Myeloma